amino semaglutide Glucagon‐like peptide‐1 and semaglutide. (a) The preproglucagon Semaglutide Weight Loss Injections in

Looking to refine your results further

The first trial enrolled participants who did not use CPAP therapy, while the second trial enrolled CPAP users at baseline

Keller J, Trautmann ME, Haber H, et al

Beyond GLP-1: Amylin & CagriSema after ECO 2026 Reflections from ECO / EASO 2026: how amylin-based therapies and CagriSema (cagrilintidesemaglutide) fit next to GLP-1 treatment, what trials suggest, and how structured obesity care is evolving

Higher doses of both medications are known to cause more severe side effects

Tightening your injection timing, making it more consistent rather than simply different, sometimes resolves what appears to be a plateau